WEIN, Austria

Sharareh Salar Behzadi

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Sharareh Salar Behzadi

Introduction

Sharareh Salar Behzadi is an accomplished inventor based in Wein, Austria. She has made significant contributions to the field of materials science, particularly in the development of innovative coating materials and transport particles for active ingredients.

Latest Patents

Sharareh holds two patents that showcase her expertise. The first patent is for a coating material used in a hot-melt coating method. This invention involves a material that contains one or more polyglycerol fatty acids, which are derived from the complete or partial esterification of a polyglycerol with fatty acids containing 6 to 22 carbon atoms. The second patent focuses on lipophilic transport particles designed for cosmetic or pharmaceutical active ingredients. These particles consist of polyglycerol fatty acid ester and are engineered to maintain stability during storage, preventing volume changes and ensuring a consistent release profile of the active ingredients.

Career Highlights

Sharareh Salar Behzadi is currently employed at Ioi Oleo GmbH, where she continues to innovate and develop new materials. Her work has positioned her as a key figure in her field, contributing to advancements that benefit both the cosmetic and pharmaceutical industries.

Collaborations

Throughout her career, Sharareh has collaborated with notable colleagues, including Dirk Lochmann and Sebastian Reyer. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Sharareh Salar Behzadi's contributions to the field of materials science through her patents and collaborations highlight her role as a leading inventor. Her work continues to influence the development of effective and stable products in the cosmetic and pharmaceutical sectors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…